Return to top of page

Matching the Needs of Patients with Those of Our Federal Health Agencies

February 12, 2015   |   Alliance for Aging Research Team   |   FDA & Regulatory Policy, National Institutes Of Health

On Tuesday, the Alliance for Aging Research responded to the U.S. House Energy and Commerce Committee 21st Century Cures Initiative and its recently released discussion draft.

Our comments (which you can download below) recognized Chairman Fred Upton (R-MI), Representative Diana DeGette (D-CO), and the House Energy and Commerce Committee staff for their efforts to undertake an initiative aimed at accelerating the pace of drug, biologic, and device development for patients with high unmet needs. Given the glacial speed of innovation for many age-related diseases, we share this desire with the committee. However, we are concerned that the draft bill in its current form threatens the ability of the National Institutes of Health and the U.S. Food and Drug Administration to fully carry out the well-meaning intent behind the 21st Century Cures Initiative. We were fortunate to have the opportunity to provide feedback on the draft bill and look forward to continuing to work with Congress as this process moves forward!

Candid Seal of Platinum Transparency 2022

The Alliance for Aging Research is a proud recipient of Candid’s Platinum Seal of Transparency.

Charity Navigator logo

The Alliance for Aging Research is proud to be rated a 4-star charity by Charity Navigator.

Living Longer and Loving It

Sign up for our monthly e-mail newsletter for the latest information on
scientific research on aging and health.